Innovation
Alsymo aims to treat patients with pulmonary hypertension
… of this pathology, a close-knit team of scientists, founders of the start-up Alsymo, are focusing on a drug that … disease, with several subgroups. The causes are poorly understood. In some cases, there is a genetic, inflammatory or … II in 2027 While Alsymo was created at an already advanced stage of technological development (TRL 4), the aim now is …Published on: